Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07695454 · ClinicalTrials.gov registry record
Imaging in Semaglutide Study
A clinical trial, sponsored by The Cleveland Clinic.
- Not yet
- Registry status
- 10
- Enrollment target
NCT07695454: Clinical Trial study, sponsored by The Cleveland Clinic.
NCT07695454 is a clinical trial that has not yet begun recruiting, run by The Cleveland Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07695454 has not yet begun recruiting, sponsored by The Cleveland Clinic.
- NOT YET RECRUITING
- Registry status
- 10 participants
- Enrollment target
Study Summary
In this preliminary observation study, the investigators will assess muscle function in terms of muscle strength and leverage imaging (MRI) and spectroscopy (31P-MRS) based techniques to assess longitudinal changes in muscle volume, quality and metabolic function in patients with T2D and obesity prescribed to semaglutide therapy. The patients will be evaluated at three time points: 1) baseline, 2) 3-month and 3) 6-month after the therapy. These longitudinal changes will then be compared and correlated with changes in physical measurements such as BMI and patient reported outcome measures (PROMs). The primary aim of our study is to investigate the longitudinal effects of semaglutide therapy on patients with T2D and obesity, on skeletal muscle strength, muscle volume, quality and metabolic function.
Primary Outcome
Longitudinal effects of semaglutide therapy on patients with Type 2 diabetes and obesity on metabolic function.
Interventions
- RADIATION 31P-MRS and MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-06-01 |
What is known before NCT07695454 opens enrollment
NCT07695454 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 31P-MRS and MRI is the first listed.
NCT07695454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07695454 about?
NCT07695454 is a clinical study titled "Imaging in Semaglutide Study". In this preliminary observation study, the investigators will assess muscle function in terms of muscle strength and leverage imaging (MRI) and spectroscopy (31P-MRS) based techniques to assess longitudinal changes in muscle volume, quality and metabolic function in patients with T2D and obesity pre...
What is the current status of trial NCT07695454?
This trial is currently not yet recruiting. The enrollment target is 10 participants. The study started on 2026-07-15. Estimated completion is 2027-06-01.
What interventions are being tested in trial NCT07695454?
The interventions under investigation include: 31P-MRS and MRI (RADIATION).
Who is sponsoring clinical trial NCT07695454?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI